دورية أكاديمية
Is elective neck dissection justified in cT2N0M0 oral cavity cancer defined according to the AJCC eighth edition staging system?
العنوان: | Is elective neck dissection justified in cT2N0M0 oral cavity cancer defined according to the AJCC eighth edition staging system? |
---|---|
المؤلفون: | Chen TM; Department of Otolaryngology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan, ROC., Terng SD; Department of Head and Neck Surgery, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan, ROC., Lee LY; Department of Pathology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Lee SR; Research Service Center for Health Information, Chang Gung University, Taoyuan, Taiwan, ROC., Ng SH; Department of Diagnostic Radiology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Kang CJ; Department of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Lin JC; Department of Radiation Oncology, Changhua Christian Hospital, Changhua, Taiwan, ROC., Chien CY; Department of Otolaryngology, Chang Gung Memorial Hospital Kaohsiung Medical Center, Chang Gung University College of Medicine, Taoyuan, Taiwan, ROC., Hua CH; Department of Otorhinolaryngology, China Medical University Hospital, Taichung, Taiwan, ROC., Wang CP; Department of Otolaryngology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan, ROC., Chen WC; Department of Radiation Oncology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Tsai YT; Department of Otorhinolaryngology-Head and Neck Surgery, Chang Gung Memorial Hospital, Chiayi, Taiwan, ROC., Tsai CY; Department of Oral and Maxillofacial Surgery, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan, ROC., Lin CY; Department of Radiation Oncology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Fan KH; Department of Radiation Oncology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Wang HM; Department of Medical Oncology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Hsieh CH; Department of Medical Oncology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Yeh CH; Department of Diagnostic Radiology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Lin CH; Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Tsao CK; Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Cheng NM; Department of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Fang TJ; Department of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Huang SF; Department of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Lee LA; Department of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Fang KH; Department of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Wang YC; Department of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Lin WN; Department of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Hsin LJ; Department of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Yen TC; Department of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC., Wen YW; Clinical Informatics and Medical Statistics Research Center, Chang Gung University, Taoyuan, Taiwan, ROC.; Division of Thoracic Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan, ROC., Liao CT; Department of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC. |
المصدر: | Cancer medicine [Cancer Med] 2024 Jan; Vol. 13 (1), pp. e6894. Date of Electronic Publication: 2024 Jan 03. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: [Malden, MA] : John Wiley & Sons Ltd., c2012- |
مواضيع طبية MeSH: | Neck Dissection* , Neoplasm Staging* , Mouth Neoplasms*/pathology , Mouth Neoplasms*/surgery , Mouth Neoplasms*/mortality , Elective Surgical Procedures*, Humans ; Male ; Female ; Middle Aged ; Aged ; Lymphatic Metastasis ; Retrospective Studies ; Adult ; Carcinoma, Squamous Cell/surgery ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/mortality ; Squamous Cell Carcinoma of Head and Neck/surgery ; Squamous Cell Carcinoma of Head and Neck/pathology ; Squamous Cell Carcinoma of Head and Neck/mortality ; Neoplasm Invasiveness ; Prognosis |
مستخلص: | Background: The current NCCN guidelines recommend considering elective neck dissection (END) for early-stage oral cavity squamous cell carcinoma (OCSCC) with a depth of invasion (DOI) exceeding 3 mm. However, this DOI threshold, determined by evaluating the occult lymph node metastatic rate, lacks robust supporting evidence regarding its impact on patient outcomes. In this nationwide study, we sought to explore the specific indications for END in patients diagnosed with OCSCC at stage cT2N0M0, as defined by the AJCC Eighth Edition staging criteria. Methods: We examined 4723 patients with cT2N0M0 OCSCC, of which 3744 underwent END and 979 were monitored through neck observation (NO). Results: Patients who underwent END had better 5-year outcomes compared to those in the NO group. The END group had higher rates of neck control (95% vs. 84%, p < 0.0001), disease-specific survival (DSS; 87% vs. 84%, p = 0.0259), and overall survival (OS; 79% vs. 73%, p = 0.0002). Multivariable analysis identified NO, DOI ≥5.0 mm, and moderate-to-poor tumor differentiation as independent risk factors for 5-year neck control, DSS, and OS. Based on these prognostic variables, three distinct outcome subgroups were identified within the NO group. These included a low-risk subgroup (DOI <5 mm plus well-differentiated tumor), an intermediate-risk subgroup (DOI ≥5.0 mm or moderately differentiated tumor), and a high-risk subgroup (poorly differentiated tumor or DOI ≥5.0 mm plus moderately differentiated tumor). Notably, the 5-year survival outcomes (neck control/DSS/OS) for the low-risk subgroup within the NO group (97%/95%/85%, n = 251) were not inferior to those of the END group (95%/87%/79%). Conclusions: By implementing risk stratification within the NO group, we found that 26% (251/979) of low-risk patients achieved outcomes similar to those in the END group. Therefore, when making decisions regarding the implementation of END in patients with cT2N0M0 OCSCC, factors such as DOI and tumor differentiation should be taken into account. (© 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.) |
References: | National comprehensive cancer network clinical practice guidelines in oncology. Head and Neck Cancers. Version I.2024, Section “PRINCIPLES OF SURGERY”, “Neck Management”, page “SURG‐A 6 OF 8”. Available at: http://www.nccn.org/(Accessed on December 4, 2023.). D'Cruz AK, Vaish R, Kapre N, et al. Head and neck disease management group. Elective versus therapeutic neck dissection in node‐negative oral cancer. N Engl J Med. 2015;373(6):521‐529. doi:10.1056/NEJMoa1506007. Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg. 1994;120(7):699‐702. doi:10.1001/archotol.1994.01880310005001. Massey C, Dharmarajan A, Bannuru RR, Rebeiz E. Management of N0 neck in early oral squamous cell carcinoma: a systematic review and meta‐analysis. Laryngoscope. 2019;129(8):E284‐E298. doi:10.1002/lary.27627. Cai H, Zhu Y, Wang C, Zhang Y, Hou J. Neck nodal recurrence and survival of clinical T1‐2 N0 oral squamous cell carcinoma in comparison of elective neck dissection versus observation: a meta‐analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;129(4):296‐310. doi:10.1016/j.oooo.2019.10.012. Abu‐Ghanem S, Yehuda M, Carmel NN, et al. Elective neck dissection vs observation in early‐stage squamous cell carcinoma of the oral tongue with no clinically apparent lymph node metastasis in the neck: a systematic review and meta‐analysis. JAMA Otolaryngol Head Neck Surg. 2016;142(9):857‐865. doi:10.1001/jamaoto.2016.1281. Wushou A, Yibulayin F, Sheng L, Luo Y, Yang ZC. Elective neck dissection improves the survival of patients with T2N0M0 oral squamous cell carcinoma: a study of the SEER database. BMC Cancer. 2021;21(1):1309. doi:10.1186/s12885-021-09053-3. Amin MB, Edge S, Greene F, et al. AJCC Cancer Staging Manual. 8th ed. Springer‐Verlag; 2017. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer. 2005;93(4):387‐391. doi:10.1038/sj.bjc.6602678. Sauerbrei W, Taube SE, McShane LM, Cavenagh MM, Altman DG. Reporting recommendations for tumor marker prognostic studies (REMARK): an abridged explanation and elaboration. J Natl Cancer Inst. 2018;110(8):803‐811. doi:10.1093/jnci/djy088. American College of Surgeons. Standards for oncology registry entry. Effective for Cases Diagnosed; 2023 https://wwwfacsorg/media/vssjur3j/store_manual_2023. Chien CY, Wang CP, Lee LY, et al. Indications for elective neck dissection in cT1N0M0 oral cavity cancer according to the AJCC eight edition: a nationwide study. Oral Oncol. 2023;140:106366. doi:10.1016/j.oraloncology.2023.106366. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373‐383. doi:10.1016/0021-9681(87)90171-8. Borgemeester MC, van den Brekel MWM, van Tinteren H, et al. Ultrasound‐guidedaspiration cytology for the assessment of the clinically N0 neck: factors influencing its accuracy. Head Neck. 2008;30(11):1505‐1513. doi:10.1002/hed.20903. Nieuwenhuis EJ, Castelijns JA, Pijpers R, et al. Wait‐and‐see policy for the N0 neck in early‐stage oral and oropharyngeal squamous cell carcinoma using ultra‐sonography‐guided cytology: is there a role for identification of the sentinel node? Head Neck. 2002;24(3):282‐289. doi:10.1002/hed.10018. Yuen AP, Ho CM, Chow TL, et al. Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck. 2009;31(6):765‐772. doi:10.1002/hed.21033. Flach GB, Tenhagen M, de Bree R, et al. Outcome of patients with early stage oral cancer managed by an observation strategy towards the N0 neck using ultrasound guided fine needle aspiration cytology: No survival difference as compared to elective neck dissection. Oral Oncol. 2013;49(2):157‐164. doi:10.1016/j.oraloncology.2012.08.006. de Bree R, Takes RP, Shah JP, et al. Elective neck dissection in oral squamous cell carcinoma: past, present and future. Oral Oncol. 2019;90:87‐93. doi:10.1016/j.oraloncology.2019.01.016. Lin CY, Fan KH, Lee LY, et al. Precision adjuvant therapy based on detailed pathological risk factors for resected oral cavity squamous cell carcinoma: long term outcome comparison of CGMH and NCCN guidelines. Int J Radiat Oncol Biol Phys. 2020;106(5):916‐925. doi:10.1016/j.ijrobp.2019.08.058. Lee LY, Lin CY, Cheng NM, et al. Poor tumor differentiation is an independent adverse prognostic variable in patients with locally advanced oral cavity cancer—Comparison with pathological risk factors according to the NCCN guidelines. Cancer Med. 2021;10(19):6627‐6641. doi:10.1002/cam4.4195. |
فهرسة مساهمة: | Keywords: cT2N0M0; cancer registry; clinical outcomes; elective neck dissection; occult lymph node metastasis; oral cavity squamous cell carcinoma |
تواريخ الأحداث: | Date Created: 20240103 Date Completed: 20240805 Latest Revision: 20240805 |
رمز التحديث: | 20240806 |
مُعرف محوري في PubMed: | PMC10807631 |
DOI: | 10.1002/cam4.6894 |
PMID: | 38169115 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2045-7634 |
---|---|
DOI: | 10.1002/cam4.6894 |